Carprieve 50 mg/ml Solution for Injection for Cattle

מדינה: הממלכה המאוחדת

שפה: אנגלית

מקור: VMD (Veterinary Medicines Directorate)

מרכיב פעיל:

Carprofen

זמין מ:

Norbrook Laboratories Limited

קוד ATC:

QM01AE91

INN (שם בינלאומי):

Carprofen

טופס פרצבטיות:

Solution for injection

סוג מרשם:

POM-V - Prescription Only Medicine – Veterinarian

קבוצה תרפויטית:

Cattle

איזור תרפויטי:

Anti Inflammatory NSAID

מצב אישור:

Authorized

תאריך אישור:

2009-07-21

מאפייני מוצר

Revised: October 2018
AN: 00782/2018
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprieve 50mg/ml Solution for Injection for Cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Carprofen
50 mg/ml
EXCIPIENTS:
Ethanol (anhydrous)
0.1 ml/ml
Sodium Formaldehyde Sulphoxylate 2.0 mg/ml
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for Injection.
A clear colourless to pale yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of pyrexia in acute cases of infectious respiratory disease
in cattle, in
combination with appropriate anti-infective therapy.
4.3
CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal
impairment.
Do not use in animals suffering from gastrointestinal ulceration or
bleeding.
Do not use where there is evidence of a blood dyscrasia.
Do not use in animals with known hypersensitivity to the product.
For use in pregnant animals refer to section 4.7.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the stated dose or the duration of treatment.
Revised: October 2018
AN: 00782/2018
Page 2 of 5
Do not administer other NSAIDs concurrently or within 24 hours of each
other.
Some NSAIDs may be highly bound to plasma proteins and compete with
other
highly bound drugs, which can lead to toxic effects.
Use in any animal less than 6 weeks of age, or in aged animals, may
involve
additional risk. If such use cannot be avoided animals may require a
reduced
dosage and careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as
there is a
potential risk of increased renal toxicity. Also refer to section 4.8.
II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Carprofen,
in
common
with
other
NSAIDs,
has
been
shown
to
exhibit
photosensitising